Virologik GmbH

Company

    • Company type:
      • Research & Development
    • Year founded:
    • 2006
    • Employees (at the site):
    • 19
    • Turnover range:
    • <5m EUR
    • Products/services:
    • ViroLogik is a product-oriented bio-pharmaceutical enterprise which develops and tests new drugs and therapy forms for the treatment of virale infection. For the innovative active principle ViroLogik has achieved preclinical proof of principle for infections with HIV (AIDS), HCV (Hepatitis C virus, hepatitis) as well as IAV (Influenza A viruses, influenza). The active principle will soon be tested with humans in clinical case studies. ViroLogik posesses extensive registered and chartered protective rights.

    • Core competencies:
    • not available

    • Language skills:
    • English
      German
    • Key Tech / section:
      • Biotechnology: Therapeutic drug development
    • Certification:
    • not available

    • Sales markets - target industries:
    • not available
    • Sales markets - target countries:
    • not available
    • Cooperation offers:
    • not available
    • Contact person:
    • Karl Appelmann (Mr.)
      - Management